InvestSMART

Australian Clinical Labs Limited (ASX: ACL) - Announcements

- Current share price for ACL : $2.220

ASX company news and announcements for Australian Clinical Labs Limited (ACL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Australian Clinical Labs Limited (ACL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Australian Clinical Labs Limited (ACL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Australian Clinical Labs Limited (ACL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$414 Becoming a substantial holder 9 Jul 2026 4:49PM $2.220 $2.220 fallen by 0%
$414 Ceasing to be a substantial holder 2 Jul 2026 5:33PM $2.230 $2.220 fallen by 0.45%
$414 Initial Director's Interest Notice - Dr Amandeep Hansra 2 Jul 2026 10:55AM $2.225 $2.220 fallen by 0.22%
$414 Notification regarding unquoted securities - ACL 29 Jun 2026 3:57PM $2.245 $2.220 fallen by 1.11%
$414 Change in substantial holding from MUFG 25 Jun 2026 5:07PM $2.220 $2.220 fallen by 0%
$414 Change in substantial holding 24 Jun 2026 3:57PM $2.135 $2.220 risen by 3.98%
$414 Appointment of non-executive director - Dr Amandeep Hansra 19 Jun 2026 8:22AM $2.190 $2.220 risen by 1.37%
$414 Update on third party cyber incident impacting SunDoctors 18 Jun 2026 8:26AM $2.260 $2.220 fallen by 1.77%
$414 Notification of cessation of securities - ACL 12 Jun 2026 2:06PM $2.180 $2.220 risen by 1.83%
$414 Becoming a substantial holder 9 Jun 2026 4:45PM $2.060 $2.220 risen by 7.77%
$414 Appointment of new Group CEO 28 May 2026 9:06AM $2.010 $2.220 risen by 10.45%
$414 Update - Notification of buy-back - ACL 27 May 2026 9:21AM $2.020 $2.220 risen by 9.90%
$414 Change in substantial holding from CBA 25 May 2026 11:54AM $1.963 $2.220 risen by 13.12%
$414 Update - Notification of buy-back - ACL 25 May 2026 9:23AM $1.970 $2.220 risen by 12.69%
$414 Update - Notification of buy-back - ACL 21 May 2026 8:38AM $1.925 $2.220 risen by 15.32%
$414 Update - Notification of buy-back - ACL 21 May 2026 8:28AM $1.925 $2.220 risen by 15.32%
$414 Change in substantial holding 21 May 2026 8:17AM $1.925 $2.220 risen by 15.32%
$414 Change in substantial holding 20 May 2026 3:33PM $1.925 $2.220 risen by 15.32%
$414 Change in substantial holding from MUFG 19 May 2026 4:55PM $1.910 $2.220 risen by 16.23%
$414 Change in substantial holding 18 May 2026 5:33PM $1.835 $2.220 risen by 20.98%
$414 Notification of cessation of securities - ACL 18 May 2026 10:25AM $1.868 $2.220 risen by 18.88%
$414 Update - Notification of buy-back - ACL 18 May 2026 10:08AM $1.885 $2.220 risen by 17.77%
$414 Update - Notification of buy-back - ACL 15 May 2026 9:00AM $1.835 $2.220 risen by 20.98%
$414 Update - Notification of buy-back - ACL 12 May 2026 9:00AM $1.930 $2.220 risen by 15.03%
$414 Update - Notification of buy-back - ACL 11 May 2026 9:24AM $1.920 $2.220 risen by 15.63%

1 - 25 of 998 results

Page 1 of 40

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.